Related Experiment Video
Updated: May 9, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Reproduction in the patient with inflammatory bowel disease
1Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK - Christian.selinger@web.de.
Minerva Gastroenterologica E Dietologica
|July 23, 2013
Summary
Women with inflammatory bowel disease (IBD) face complex decisions regarding pregnancy and treatment. Balancing IBD management with reproductive health is crucial for positive outcomes in mothers and infants.
Area of Science:
- Gastroenterology and Reproductive Medicine
Background:
- Inflammatory bowel disease (IBD) frequently affects women of childbearing age, complicating fertility, pregnancy, and postpartum periods.
- Poor patient awareness of pregnancy-related issues can lead to suboptimal treatment decisions and negative perceptions of IBD therapies.
- Untreated IBD poses risks to both mother and infant, necessitating a careful balance with the potential risks of IBD treatments.
Purpose of the Study:
- To review recent advancements in understanding the interplay between IBD and reproductive health.
- To discuss the complexities of IBD treatment during pregnancy, considering maternal and infant outcomes.
- To highlight the implications of biological therapies on infant development and vaccination schedules.
Main Methods:
- Literature review of recent studies on IBD, pregnancy, and reproductive outcomes.
- Analysis of data regarding the safety and efficacy of IBD treatments during gestation and lactation.
- Examination of the impact of biological therapies on infant health and development.
Main Results:
- Emerging data support the safe use of certain IBD treatments during pregnancy.
- IBD treatments can have effects on infants for up to six months postpartum, impacting vaccination planning.
- Achieving optimal outcomes requires a personalized approach, weighing treatment risks against the risks of active disease.
Conclusions:
- Effective management of IBD in women of childbearing age necessitates a comprehensive strategy addressing fertility, pregnancy, and lactation.
- Continued research is vital to refine treatment guidelines and ensure the well-being of both mothers and infants affected by IBD.
- Enhanced patient education is essential to empower women with IBD to make informed decisions about their reproductive health and treatment options.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...